Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS).
2017
Research Type: Other Scholarly Work
Impact of Differences in Once- vs Twice-Daily Medications Adherence on the Risk of Bleed and Stroke in Non-Valvular Atrial Fibrillation: Analysis of Randomized Trials and Claims Data Sources
2017
Research Type: Poster/Presentation
Effectiveness and Safety of Apixaban and Rivaroxaban Versus Warfarin for the Secondary Prevention of Stroke or Systemic Embolism Among Nonvalvular Atrial Fibrillation Patients
2017
Research Type: Poster/Presentation
REAL-WORLD EVIDENCE OF STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES: THE REVISIT-US STUDY
2017
Research Type: Poster/Presentation
Importance of Balanced Follow-up Time and Other Study Design Considerations When Evaluating Adherence Using Two Novel Oral Anticoagulants
2017
Research Type: Poster/Presentation
External validation of a multivariable claims-based prediction rule for in-hospital pulmonary embolism mortality
2017
Research Type: Poster/Presentation
“Advantages of Once Daily Dosing on Medication Adherence and Persistence”.
2017
Research Type: Poster/Presentation
The Association Between Comorbid Atrial Fibrillation and the Type of Coronary Stent Implanted in Acute Coronary Syndrome Patients.
2017
Research Type: Poster/Presentation
Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.
2018
Research Type: Journal Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism.
2018
Research Type: Journal Article
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban.
2018
Research Type: Journal Article
Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.
2018
Research Type: Journal Article
Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis.
2018
Research Type: Journal Article
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.
2018
Research Type: Journal Article